Cost-effectiveness of interferon treatment for hepatitis C
Van Leeuwen, D.J.
JAMA 281(22): 2083-2084
1999
ISSN/ISBN: 0098-7484 PMID: 10367810 Document Number: 506478
Document emailed within 1 workday
Related Documents
Aggarwal, R.; Ghoshal, U.C.; Naik, S.R. 2002: Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries National Medical Journal of India 15(6): 320-327Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111
Khokhar, N. 2002: Effectiveness of 48 weeks Interferon alfa-2b in combination with ribavirin as initial treatment of chronic hepatitis Journal of Ayub Medical College Abbottabad: Jamc 14(3): 5-8
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Hudecková, H.; Straka, S.; Szilágyiová, M.; Avdicová, M.; Rusnáková, S. 2002: Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic Central European Journal of Public Health 10(4): 146-148
Zhang, S.X. 1992: Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis Zhonghua Yu Fang Yi Xue Za Zhi 26(3): 154-158
Sakuma, I.; Enomoto, N.; Asahina, Y.; Kurosaki, M.; Sato, C. 1995: Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 930-935
Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66
Kahn, J.G.; Jiwani, A.; Gomez, G.B.; Hawkes, S.J.; Chesson, H.W.; Broutet, N.; Kamb, M.L.; Newman, L.M. 2014: The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model PLOS one 9(1): E87510
Granich, R.; Kahn, J.G.; Bennett, R.; Holmes, C.B.; Garg, N.; Serenata, C.; Sabin, M.Lewis.; Makhlouf-Obermeyer, C.; De Filippo Mack, C.; Williams, P.; Jones, L.; Smyth, C.; Kutch, K.A.; Ying-Ru, L.; Vitoria, M.; Souteyrand, Y.; Crowley, S.; Korenromp, E.L.; Williams, B.G. 2012: Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050 PloS one 7(2): e30216
Wessels, F.; Anderson, A.N.; Kropman, K. 1999: The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. a cost-minimisation pharmaco-economic model South African Medical Journal 89(7 Part 2): 791-794
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
David, Y.J.; Tahir, A.; Riaz, M. 2017: Cost effectiveness evaluation of hepatitis C therapy in Lahore Pakistan Journal of Pharmaceutical Sciences 30(6): 2233-2237
Abe, Y.; Ueda, T.; Kato, T.; Kohli, Y. 1994: Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 52(7): 1817-1822
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Wessels, F.; Anderson, A.N.; Kropman, K. 1999: The cost-effectiveness of isotretinoin in the treatment of acne. Part 1. A meta-analysis of effectiveness literature South African Medical Journal 89(7 Pt 2): 780-784
Thurgar, E.; Barton, S.; Karner, C.; Edwards, S.J. 2016: Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation Health Technology Assessment 20(24): V-Vi 1-486
Kania, D.; Sangaré, L.; Sakandé, J.; Koanda, A.; Nébié, Y.K.; Zerbo, O.; Combasséré, A.W.; Guissou, I.P.; Rouet, F.ço. 2009: A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso Transfusion 49(10): 2237-2240
Betegón, L.; Cotarelo, M.; Vendrell, Bén. 2012: Cost and cost-effectiveness analysis of the preferred treatment for initial antiretroviral therapy in HIV infected adults according to 2012 GESIDA/National AIDS Plan guidelines Enfermedades infecciosas y microbiologia clinica 30(8): 508-9; author reply 511-2